Danaher Net Income 2010-2025 | DHR

Danaher annual/quarterly net income history and growth rate from 2010 to 2025. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
  • Danaher net income for the quarter ending March 31, 2025 was $954M, a 12.32% decline year-over-year.
  • Danaher net income for the twelve months ending March 31, 2025 was $3.765B, a 14.47% decline year-over-year.
  • Danaher annual net income for 2024 was $3.899B, a 17.79% decline from 2023.
  • Danaher annual net income for 2023 was $4.743B, a 33.23% decline from 2022.
  • Danaher annual net income for 2022 was $7.103B, a 13.3% increase from 2021.
Danaher Annual Net Income
(Millions of US $)
2024 $3,899
2023 $4,743
2022 $7,103
2021 $6,269
2020 $3,510
2019 $2,940
2018 $2,651
2017 $2,492
2016 $2,554
2015 $3,357
2014 $2,598
2013 $2,695
2012 $2,392
2011 $2,172
2010 $1,793
2009 $1,152
Danaher Quarterly Net Income
(Millions of US $)
2025-03-31 $954
2024-12-31 $1,086
2024-09-30 $818
2024-06-30 $907
2024-03-31 $1,088
2023-12-31 $1,079
2023-09-30 $1,129
2023-06-30 $1,106
2023-03-31 $1,429
2022-12-31 $2,210
2022-09-30 $1,551
2022-06-30 $1,658
2022-03-31 $1,684
2021-12-31 $1,747
2021-09-30 $1,117
2021-06-30 $1,744
2021-03-31 $1,661
2020-12-31 $1,200
2020-09-30 $842
2020-06-30 $892
2020-03-31 $576
2019-12-31 $1,256
2019-09-30 $648
2019-06-30 $709
2019-03-31 $327
2018-12-31 $747
2018-09-30 $664
2018-06-30 $674
2018-03-31 $567
2017-12-31 $857
2017-09-30 $572
2017-06-30 $557
2017-03-31 $506
2016-12-31 $747
2016-09-30 $392
2016-06-30 $657
2016-03-31 $758
2015-12-31 $689
2015-09-30 $1,403
2015-06-30 $696
2015-03-31 $570
2014-12-31 $662
2014-09-30 $681
2014-06-30 $676
2014-03-31 $580
2013-12-31 $789
2013-09-30 $597
2013-06-30 $617
2013-03-31 $692
2012-12-31 $630
2012-09-30 $549
2012-06-30 $600
2012-03-31 $613
2011-12-31 $571
2011-09-30 $523
2011-06-30 $649
2011-03-31 $429
2010-12-31 $474
2010-09-30 $646
2010-06-30 $372
2010-03-31 $300
2009-12-31 $267
2009-09-30 $351
2009-06-30 $296
2009-03-31 $238
Sector Industry Market Cap Revenue
Medical Medical Services $145.316B $23.875B
Danaher Corporation is a global conglomerate that designs, manufactures and markets diverse lines of professional, industrial, commercial and consumer products. The company's segmental details are provided below: Life Sciences segment offers a broad range of research tools used to analyze a range of critical areas including genes, proteins, metabolites and cells to understand the causes of diseases, identify new therapies, and test new drugs and vaccines. Range of industries served includes biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial. Diagnostics segment offers analytical instruments, reagents, consumables, software and services that are deployed in reference laboratories, hospitals, physicians' offices and other critical care settings. It helps to diagnose diseases and take suitable treatment decisions. Environmental & Applied Solutions segment offers products and services that help keep food and water supplies safe globally.
Stock Name Country Market Cap PE Ratio
CVS Health (CVS) United States $75.446B 9.38
Elevance Health (ELV) United States $64.396B 8.66
Cencora (COR) United States $55.472B 19.30
DiDi Global (DIDIY) China $25.980B 27.60
Labcorp Holdings (LH) United States $21.919B 17.30
Natera (NTRA) United States $18.843B 0.00
BioMerieux (BMXMF) France $17.068B 0.00
ICON (ICLR) Ireland $15.316B 14.74
EUROFINS SCIENT (ERFSF) Luxembourg $14.929B 0.00
CochLear (CHEOY) Australia $13.403B 0.00
Solventum (SOLV) United States $12.763B 13.51
Medpace Holdings (MEDP) United States $12.728B 33.68
Revvity (RVTY) United States $11.202B 19.44
Viatris (VTRS) United States $10.868B 3.73
Avantor (AVTR) United States $9.533B 13.85
Sonic Healthcare (SKHHY) Australia $9.208B 0.00
Charles River Laboratories (CRL) United States $8.791B 17.23
HealthEquity (HQY) United States $8.281B 36.27
Caris Life Sciences,�Inc (CAI) United States $6.884B 0.00
Amplifon S.p.A (AMFPF) Italy $5.378B 29.44
Bausch + Lomb (BLCO) Canada $5.109B 30.08
BrightSpring Health Services (BTSG) United States $3.600B 33.03
Sotera Health (SHC) United States $3.489B 19.82
Surgery Partners (SGRY) United States $2.876B 37.40
Organon (OGN) United States $2.592B 2.75
Concentras Parent (CON) United States $2.576B 14.89
GeneDx Holdings (WGS) United States $2.423B 93.31
Alignment Healthcare (ALHC) United States $2.346B 0.00
Progyny (PGNY) United States $1.989B 43.77
PACS (PACS) United States $1.792B 0.00
GoodRx Holdings (GDRX) United States $1.789B 35.79
Premier (PINC) United States $1.739B 13.20
Ardent Health (ARDT) United States $1.525B 6.50
Teladoc Health (TDOC) United States $1.439B 0.00
Establishment Labs Holdings (ESTA) $1.228B 0.00
Pediatrix Medical (MD) United States $1.088B 8.28
Ryman Healthcare (RYHTY) New Zealand $0.970B 0.00
QDM (QDMI) Hong Kong, SAR China $0.875B 300.00
Agilon Health (AGL) United States $0.824B 0.00
AMN Healthcare Services Inc (AMN) United States $0.753B 7.05
CareDx (CDNA) United States $0.712B 11.12
Embecta (EMBC) United States $0.662B 4.46
Nutex Health (NUTX) United States $0.513B 7.77
So-Young (SY) China $0.513B 0.00
InnovAge Holding (INNV) United States $0.506B 0.00
LifeMD (LFMD) United States $0.494B 0.00
Omada Health (OMDA) $0.478B 0.00
SBC Medicals (SBC) United States $0.477B 0.00
Sonida Senior Living (SNDA) United States $0.467B 0.00
Auna S.A (AUNA) Luxembourg $0.457B 10.28
COMPASS Pathways (CMPS) United Kingdom $0.406B 0.00
Enhabit (EHAB) United States $0.344B 28.29
Oncology Institute (TOI) United States $0.336B 0.00
Performant Healthcare (PHLT) United States $0.286B 0.00
Beauty Health (SKIN) United States $0.222B 0.00
Pheton Holdings (PTHL) China $0.204B 0.00
DocGo (DCGO) United States $0.152B 24.83
Sera Prognostics (SERA) United States $0.118B 0.00
Ascend Wellness Holdings (AAWH) United States $0.086B 0.00
KindlyMD (NAKA) United States $0.077B 0.00
Biodesix (BDSX) United States $0.061B 0.00
NeueHealth (NEUE) United States $0.060B 0.00
IceCure Medical (ICCM) Israel $0.060B 0.00
ModivCare (MODV) United States $0.044B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.042B 0.00
Basel Medical Group (BMGL) Singapore $0.041B 0.00
OSR Holdings (OSRH) United States $0.018B 0.00
Intelligent Bio Solutions (INBS) United States $0.011B 0.00
Co-Diagnostics (CODX) United States $0.009B 0.00
SeaStar Medical Holding (ICU) United States $0.009B 0.00
BioNexus Gene Lab (BGLC) $0.008B 0.00
XWELL (XWEL) United States $0.006B 0.00
Aclarion (ACON) United States $0.005B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
NewGenIvf Group (NIVF) Thailand $0.002B 0.00
INVO Fertility (IVF) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.000B 0.00